2Grogan TM,Van Camp B,Kyle RA,et al.Plasma cell neoplasma.In:Jaffe ES,Harris NL,Stein H,et al.Pathology and genetics of tumours haematopoietic and lymphoid tissuses.WHO classification of tumous[J].IARC Press Lyou,2001,144.
3Wilder RB,Ha CS,Cox JD,et al.Persistence of myeloma protein formore than one year after radiotherapy is an adverse prognostic factor insolitary plasmacytoma of bone.cancer,2002,94:1532-1537.
2Dimopoulos MA, Moulopoulos LA, Maniatis A, et al. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood, 2000, 96: 2037-2044.
3Mayer JE, Schulz MD. "Solitary" myeloma of bone: a review of 12 cases. Cancer, 1974, 34: 438-440.
4Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer, 1981, 48: 845-851.
5Jackson A, Scarffe JH. Prognostic significance of osteopenia and immunoparesis at presentation in patients with solitary myeloma of bone. Eur J Cancer, 1990, 26: 363-371.
6Brinch L, Hannisdal E, Foss Abrahamsen A, et al. Extramedullary plasmacytomas and solitary plasma cell tumors of bone. Eur J Haematol, 1990, 44: 131-134.
7Bolek TW, Marcus RD, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Onco Biol Phys, 1996, 36: 329-333.
8Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Onco Biol Phys, 1998, 441: 1063-1067.
9Wilder RB, Ha CS, Cox JD, et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer, 2002, 94: 1532-1537.
10Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytoma. Radiother Oncol, 1990, 17: 297-303.
